LDCT-based lung cancer screening and small cell lung cancer: Limited but non-negligible impact on survival. A brief report
Low-dose computed tomography (LDCT)-based lung cancer screening (LCS) seems to have very limited impact on small cell lung cancer (SCLC) outcomes. This study aims at describing frequency and outcomes of SCLC in a large LCS population.
Patients diagnosed with SCLC among the total population enrolled in three different trials (n = 7473) were selected for the present analysis.